Replies to post #650 on Enanta Pharmaceuticals Inc (ENTA)

[biotech_researcher]

I have a great position in this (thanks to DEW's DD), with an $18.xx cost basis, so I guess the question is what is next? It sure looks like approval is baked in? Will selling come on the news? It has the feel that that may be the case. The earning leverage with such a low share count, has kept me here. And, no one really knows much about this company. A paired trade might be to buy PUTS on GILD before approval of Abbie/ENTA's entry.